South Dakota
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Indigenous peoples in South Dakota are most likely to be diagnosed with lung cancer
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in South Dakota is 54.0 and not significantly different than the national rate of 52.8.
 - It ranks 24th among all states, placing it in the average tier.
 - Over the last five years, the rate of new cases in South Dakota did not change significantly.
 - In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
 
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) is 29.7% nationally.
 - South Dakota is one of the 12 states for which survival data is not available, as they do not track cases after diagnosis.
 
Early Diagnosis:
- In South Dakota, 30.8% of cases are caught at an early stage, which is significantly higher than the national rate of 28.1%.
 - It ranks 10th among the 50 states with data on diagnosis at an early stage, placing it in the above average tier.
 - Over the last five years, the early diagnosis rate in South Dakota did not change significantly.
 
Lung Cancer Treatment
Biomarker Coverage:
- South Dakota has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
 
Surgical Treatment:
- South Dakota ranked 47th (out of the 49 states with available data) with 14.7% of cases undergoing surgery as part of the first course of treatment.
 - This is significantly lower than the national rate of 20.7% and puts South Dakota in the bottom tier.
 - Over the last five years, the percent of cases undergoing surgery in South Dakota did not change significantly.
 
No Treatment:
- South Dakota ranked 23rd (out of the 49 states with available data) with 19.6% of cases not receiving any treatment.
 - This is not significantly different than the national rate of 21.0% and puts South Dakota in the average tier.
 - Over the last five years, the percent of cases receiving no treatment in South Dakota did not change significantly.
 
Screening
Screening for High Risk:
- In South Dakota, 18.3% of those at high risk were screened, which was not significantly different than the national rate of 18.2%.
 - It ranks 28th among all states, placing it in the average tier.
 - Screening rates in this year’s report have been updated to correct an error in the data source and should not be compared to previous reports.
 
Prevention
Tobacco Use:
- The 2023 smoking rate in South Dakota is 15.2% and significantly higher than the national rate of 11.4%.
 - It ranks 43rd among all states, placing it in the below average tier.
 
Radon Exposure:
- In South Dakota, 59.8% of radon test results were at or above the action level recommended by EPA.
 - It ranks 51st among all states, placing it in the bottom tier.
 
Racial & Ethnic Disparities
Black individuals:
- Lung cancer rates are not available for Black individuals in South Dakota due to too few cases over the time period to allow for accurate analysis.
 
Latino individuals:
- The rate of new lung cancer cases is 26.4 per 100,000 population among Latino individuals in South Dakota, not significantly different than the rate of 27.9 among Latino individuals nationally, and significantly lower than the rate of 53.3 among white individuals in South Dakota.
 - State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
 - Other lung cancer rates are not available for Latino individuals in South Dakota due to too few cases over the time period to allow for accurate analysis.
 
Asian or Pacific Islanders individuals:
- Lung cancer rates are not available for Asian or Pacific Islander individuals in South Dakota due to too few cases over the time period to allow for accurate analysis.
 
Indigenous Peoples:
- The rate of new lung cancer cases is 86.7 per 100,000 population among Indigenous peoples (American Indians/Alaska Natives) in South Dakota, significantly higher than the rate of 39.8 among Indigenous Peoples nationally, and significantly higher than the rate of 53.3 among white individuals in South Dakota.
 - State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
 - 26.8% of lung cancer cases are diagnosed at an early stage among Indigenous peoples (American Indians/Alaska Natives) in South Dakota, not significantly different than the rate of 25.2% among Indigenous peoples (American Indians/Alaska Natives) nationally, and not significantly different than the rate of 31.2% among white individuals in South Dakota.
 - 27.8% of Indigenous peoples (American Indians/Alaska Natives) with lung cancer in South Dakota did not receive any treatment, not significantly different than the rate of 25.0% among Indigenous peoples (American Indians/Alaska Natives) nationally, and significantly higher than the rate of 19.1% among white individuals in South Dakota.
 - Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in South Dakota due to too few cases over the time period to allow for accurate analysis.
 
Summary
Despite the early diagnosis rate in South Dakota falling into the above average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
South Dakota has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
South Dakota falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 29, 2025
